Panel – Lessons Learnt from Obesity & Diabetes to Inform Market Access Strategies for Wider Cardiometabolic Indications
Time: 4:30 pm
day: Conference Day One
Details:
- Understanding common barriers to patient access and affordability for treatments in these areas to consider how cost-sharing arrangements can be effectively navigated
- Understanding how availability of existing treatments and the pipeline of new therapies differ across CVRM disease areas effects market access dynamics
- Uncovering best practices in market access that have been applied in one disease area that could be applied to others to share lessons leant and avoid future bottlenecks
